Opiant Pharmaceuticals, Inc.

Common Stock SEC Reporting - Current
Verified Company Profile 11/15/2016
Contact Info
  • 401 Wilshire Blvd.
  • 12th Floor
  • Santa Monica, CA 90401

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Oct 31, 2016 10-Q
CIK 0001385508
Fiscal Year End 7/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 1000 - Metal Mining
Incorporated In: NV, USA
Year of Inc. 2005
Employees 7 a/o Nov 04, 2016
Company Officers/Contacts
Roger Crystal CEO, President
Kevin Pollack CFO, Treasurer, Secretary
Company Directors
Michael Sinclair Chairman, Executive Chairman
Roger Crystal
Ann MacDougall
Kevin Pollack
Gabrielle Silver
Thomas T. Thomas
Geoffrey Wolf
Service Providers
Accounting/Auditing Firm
MaloneBailey, LLP
9801 Westheimer Road
Suite 1100
Houston, TX, 77042
United States
Securities Counsel
DLA Piper
1251 Avenue of the Americas
New York, NY, 10020-1104
United States
Investor Relations Firm

Not Available
Company History
  • Formerly=Lightlake Therapeutics Inc. until 3-2016
  • Formerly=Madrona Ventures, Inc. until 10-2009
OPNT Security Details
Share Structure
Market Value1 $15,887,851 a/o Feb 27, 2017
Authorized Shares 200,000,000 a/o Jan 30, 2017
Outstanding Shares 2,036,904 a/o Jan 30, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value No Par Value
Transfer Agent(s) Verified by Transfer Agent
VStock Transfer LLC
Shareholders of Record 148 a/o Oct 28, 2016
Short Selling Data
Short Interest 1,769 (99.44%)
Jan 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security